Additionally, it has been shown that there are changes in the relative distribution of the receptor for advanced glycation end products (RAGE) and LRP in the blood brain barrier of the human hippocampus of patients with Alzheimer's disease; as levels of RAGE increase then levels of LRP are decreased [33]. The gene discussed is LRP1; the disease is Alzheimer disease.